Triglycerides, Glucose Metabolism, and Type 2 Diabetes

Area of Science:

• Metabolic disorders
• Endocrinology
• Diabetes research

Background:

• Type 2 diabetes (T2D) is a significant global health issue with rising prevalence.
• Elevated triglyceride levels correlate with increased plasma glucose and T2D risk, suggesting a causal link.
• Understanding the interplay between triglycerides and glucose metabolism is crucial for T2D pathogenesis.

Purpose of the Study:

• To review the metabolic interconversion between triglycerides and glucose.
• To elucidate how ectopic triglyceride accumulation contributes to T2D development.
• To discuss the efficacy of different interventions and therapies for T2D.

Main Methods:

• Literature review of metabolic pathways and signaling.
• Analysis of clinical intervention studies (bariatric surgery, dietary restriction).
• Examination of the effects of specific fatty acids and medications on T2D.

Main Results:

• Excess carbohydrate intake promotes ectopic triglyceride accumulation, enhancing hepatic gluconeogenesis.
• Ectopic fat deposition drives insulin resistance, hyperinsulinemia, and beta-cell dysfunction.
• Reversal of T2D via bariatric surgery and energy restriction supports the role of ectopic fat.

Conclusions:

• Ectopic triglyceride accumulation, driven by obesity and lifestyle, is a key factor in T2D onset and progression.
• Omega-3 fatty acids and niacin do not prevent T2D despite lowering triglycerides, unlike fibrates.
• Targeting ectopic fat accumulation offers promising therapeutic strategies for T2D management.